Joe D’Ambrosio

Joe D’Ambrosio is a Partner with Clarkston Consulting. He has over 20 years of experience in strategy, process, organization, and information technology consulting. He has worked in a variety of industries addressing business challenges across new product development, sales and marketing, customer service, supply chain, quality, regulatory, manufacturing, distribution, logistics, finance and human resources.

He has served as an advisor to senior executives helping them to envision and implement breakthrough strategies to drive business results. He has worked on Clarkston’s largest and most comprehensive global enterprise projects providing strategy, planning, program management and execution support..

In his 12+ years with Clarkston, Joe has served as a Strategy Consultant, Project Manager, Consulting Partner, Chief Services Officer, and was the North Regional Managing Partner from 2005 – 2009. He has consulted to industry leaders in the following business segments

Joe is active in several life sciences and charitable organizations. He has a B.S. in industrial management from Carnegie Mellon University.

Most Recent Blog Posts

The Generic Drug Industry – Can’t get more global than that » Posted on 5/9/2012 by Joe D'Ambrosio http://www.clarkstonconsulting.com/the-generic-drug-industry-cant-get-more-global-than-that » If you have been keeping up with my blog, you are aware of the FDA’s inspection classification database, and the positive quality results it represents for generics manufacturers. This database is the best source I have found for providing a consolidated and comprehensive view of FDA inspection activity.  And whereas it does not provide the specifics of inspection results, it does provide the “district decision”...

Quality in Generic Pharmaceuticals - A review of FDA inspection data » Posted on 4/18/2012 by Joe D'Ambrosio http://www.clarkstonconsulting.com/quality-in-generic-pharmaceuticals-a-review-of-fda-inspection-data » This next blog post in my series on quality in generic pharmaceutical manufacturing breaks down very interesting FDA inspection data to present some facts that reinforce the quality mandate of generics manufacturers. If you’ve ever tried to review and evaluate FDA inspection data, you know that it isn’t exactly easy to do.  This is especially true if you want to look at it in total over a given period of time.  You...

Generic Manufacturing – A Finely Tuned Machine » Posted on 3/26/2012 by Joe D'Ambrosio http://www.clarkstonconsulting.com/generic-manufacturing-a-finely-tuned-machine » If you have been following this forum, you will recall that for the next three months I am going to be blogging on quality in generic pharmaceuticals.  Again, my premise is that generics have become better at manufacturing then their branded counterparts.  Now let me start by saying that I’m certainly not here to knock big pharma.  We need them to be great at innovating new life saving medicines and bringing these life...